Contact
 
News about the Enterprise

Join the Enterprise and Partners for a Webinar on a New Tool to Help Optimize HIV Vaccine Research - October 29, 2013

The Enterprise held a webinar on the challenges facing researchers who want to advance their vaccine candidate from preclinical studies to a first-in-human trial. The webinar introduced a new interactive webtool designed to help researchers navigate the landscape of expertise necessary for such transition and to provide estimated timelines and costs. Click here to view the webinar.

AIDS Vaccine 2013 Webcasts and Resources - October 16, 2013

AIDS Vaccine 2013 welcomed more than 900 of the world's leading vaccine researchers, funders and policy makers to Barcelona, Spain for four days of exchange, debate and direction-setting for the field. Check out the conference webcasts, http://www.aidsvaxwebcasts.org/ and ePosters, http://epostersonline.com/aidsvax2013.

Experts to Report On Advances in The Search For The Ultimate HIV Prevention Tool – A Vaccine – At AIDS Vaccine 2013 - September 25, 2013

More than 450 research studies outlining the latest advances and obstacles in the search for an AIDS vaccine will be presented and debated at AIDS Vaccine 2013, the world's only scientific meeting dedicated exclusively to HIV vaccine research.

Functional Glycomics in HIV Vaccine Design: Funding Opportunity and Workshop Report - August 1, 2013

The NIH is offering R01 grants to help investigate structural and conformational features of HIV glycosylation that may lead to novel HIV vaccine design approaches; and to elucidate the impact of differential glycosylation on the quality of the immune response to HIV.  The deadline to apply is 02 December, http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-056.html.

Latebreaker Abstracts - July 29, 2013

The deadline to submit later breaker abstracts for AIDS Vaccine 2013 is 11 August.  To submit yours, visit http://precis.preciscentral.com/User/UserLogin.asp?Action=New&EventID=48ab2f9b

Enterprise and Partners Explore New Timely Topics in HIV Vaccines - July 1, 2013

The Enterprise and partners will focus on identifying synergies between therapeutic and preventive HIV vaccines and exploring strategies to generate long-lasting immune responses from an HIV vaccine

Timely Topics in HIV Vaccines: VISP Meeting Report - June 25, 2013

The Enterprise and partners held a consultation on 14 - 15 March 2013 around the issue of VISP/R.  The full meeting report is available to download below.

A Glimpse at our HIV Vaccine History - June 25, 2013

In a brief history of the global effort to develop a preventive HIV vaccine (Vaccine 2013, in press), Enterprise champion, Jose Esparza has set down the highs and lows of 30 years of research and development on HIV vaccines that have brought us where we are today. This is an important contribution because many senior HIV vaccine scientists have forgotten what we did and why we did it and, conversely, many younger scientists are not aware of those past efforts.

Enterprise Secretariat Report on the 2013 HVTN Full Group Meeting - June 4, 2013

The Enterprise Secretariat attended the 2013 HVTN Full Group meeting in May and developed a report on sessions attended.  Check out the report here.

AVAC Opinion Piece -- In an Unpredictable HIV Vaccine Search, Hope Still Reigns - May 20, 2013

In a  Huffington Post opinion piece, Mitchell Warren, AVAC executive director, encourages the field to step up the pace further.

Syndicate content
Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account